Position in TECH
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$10,375,909
-$1,770,826 QoQ
Shares Held
198,544
-3.9% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 81.35476267225401.ToString("F0")%
Shared 0.ToString("F0")%
None 18.645237327745992.ToString("F0")%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WCM INVESTMENT MANAGEMENT, LLC holds $637,777,114 across 17 Biotechnology names. TECH ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,121,341 | $500,723,610 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
107,817 | $18,223,229 | |
| 3 | KYMR |
Kymera Therapeutics, Inc.
|
152,381 | $12,691,813 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
167,983 | $12,474,417 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
23,560 | $12,332,953 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
171,575 | $10,757,752 | |
| 7 | TECH |
BIO-TECHNE Corp
This page
|
198,544 | $10,375,909 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
104,989 | $10,210,180 |
All Filings in TECH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,375,909 | 198,544 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $12,146,735 | 206,542 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $12,092,849 | 217,380 | Shares | Sole | 2025-11-04 | |
| 2024-12-31 | $1,697,458 | 23,566 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,829,677 | 22,891 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,234,672 | 17,232 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $930,555 | 13,220 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $1,005,317 | 13,029 | Shares | Sole | 2024-01-29 | |
| No filing history on record for this holder in this stock. | ||||||